Who owns ACUMEN PHARMACEUTICALS INC?
- Ticker: ABOS
- CUSIP Number: 00509g209
Tip: Access positions for across all investors
Analyze quarterly positions in Acumen Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acumen Pharmaceuticals stock
Who bought or sold ACUMEN PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 15M | $26M | 0% | Sep 2025 |
|
| Sands Capital Ventures | 3.4M | $7.2M | 0% | Dec 2025 |
|
| Franklin Resources | 2.3M | $4.9M | 0% | Dec 2025 |
|
| FMR | 2.0M | $3.5M | 0% | Sep 2025 |
|
| Vanguard Group | 1.7M | $3.5M | 0% | Dec 2025 |
|
| Knollwood Investment Advisory | 1.6M | $3.4M | 0% | Dec 2025 |
|
| Alyeska Investment Group | 940k | $2.0M | 0% | Dec 2025 |
|
| ADAR1 Capital Management | 891k | $1.9M | 0% | Dec 2025 |
|
| Laurion Capital Management | 867k | $1.8M | 0% | Dec 2025 |
|
| Pathstone Holdings | 859k | $1.8M | 0% | Dec 2025 |
|
| Hudson Bay Capital Management | 725k | $1.5M | 0% | Dec 2025 |
|
| Millennium Management | 602k | $1.0M | -69% | Sep 2025 |
|
| Citadel Advisors | 506k | $865k | 3436% | Sep 2025 |
|
| Two Sigma Advisers | 424k | $724k | -1% | Sep 2025 |
|
| Renaissance Technologies | 423k | $893k | -28% | Dec 2025 |
|
| Geode Capital Management | 410k | $866k | 3% | Dec 2025 |
|
| SG Americas Securities | 401k | $846k | -1% | Dec 2025 |
|
| Susquehanna International | 373k | $787k | 74% | Dec 2025 |
|
| Ikarian Capital | 254k | $537k | -4% | Dec 2025 |
|
| Two Sigma Investments | 199k | $341k | -1% | Sep 2025 |
|
| Bridgeway Capital Management | 190k | $325k | 65% | Sep 2025 |
|
| BlackRock | 170k | $358k | -3% | Dec 2025 |
|
| Acadian Asset Management | 153k | $320k | 96% | Dec 2025 |
|
| Jane Street | 142k | $300k | -31% | Dec 2025 |
|
| Goldman Sachs Group | 118k | $249k | -20% | Dec 2025 |
|
| State Street Corporation | 100k | $211k | -6% | Dec 2025 |
|
| Catalyst Financial Partners | 90k | $189k | 0% | Dec 2025 |
|
| Northern Trust | 75k | $159k | 16% | Dec 2025 |
|
| Prospera Financial Services | 50k | $106k | 100% | Dec 2025 |
|
| XTX Topco | 50k | $105k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 49k | $104k | 13% | Dec 2025 |
|
| Quadrature Capital | 49k | $104k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 48k | $101k | 46% | Dec 2025 |
|
| Boothbay Fund Management | 40k | $84k | -22% | Dec 2025 |
|
| Point72 Asset Management | 36k | $77k | 100% | Dec 2025 |
|
| Intrepid Financial Planning Group | 30k | $64k | 0% | Dec 2025 |
|
| Barclays | 30k | $63k | 0% | Dec 2025 |
|
| Catalyst Funds Management Pty | 30k | $63k | 0% | Dec 2025 |
|
| Cubist Systematic Strategies | 24k | $41k | 100% | Sep 2025 |
|
| OMERS Administration Corporation | 23k | $47k | 100% | Dec 2025 |
|
| UBS Group | 22k | $47k | -30% | Dec 2025 |
|
| Marshall Wace | 21k | $44k | 100% | Dec 2025 |
|
| PFG Investments | 19k | $40k | 65% | Dec 2025 |
|
| Independent Advisor Alliance | 19k | $40k | 100% | Dec 2025 |
|
| Pinnacle Wealth Management Advisory | 18k | $38k | 0% | Dec 2025 |
|
| Gail Mannix | 18k | $38k | 0% | Dec 2025 |
|
| Clune & Associates | 17k | $28k | 0% | Sep 2025 |
|
| Point72 Asia | 16k | $27k | -25% | Sep 2025 |
|
| Virtu Financial | 11k | $23k | 100% | Dec 2025 |
|
| Nine Masts Capital | 11k | $22k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 7.1k | $15k | 9% | Dec 2025 |
|
| Advisor Group Holdings | 6.9k | $15k | -6% | Dec 2025 |
|
| Group One Trading | 4.8k | $10k | -39% | Dec 2025 |
|
| Tower Research Capital | 4.5k | $9.4k | 100% | Dec 2025 |
|
| Larson Financial Group | 4.3k | $9.2k | 9% | Dec 2025 |
|
| Pnc Financial Services | 3.1k | $6.5k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 3.0k | $5.3k | 100% | Sep 2025 |
|
| Rockefeller Capital Management | 3.0k | $6.3k | 0% | Dec 2025 |
|
| TFC Financial Management | 2.5k | $5.3k | 0% | Dec 2025 |
|
| NISA Investment Advisors | 1.2k | $2.6k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.2k | $2.6k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 1.1k | $1.6k | 16% | Sep 2025 |
|
| SBI Securities | 518.00 | $885.987200 | 1% | Sep 2025 |
|
| EverSource Wealth Advisors | 407.00 | $859.014200 | 0% | Dec 2025 |
|
| Flagship Harbor Advisors | 350.00 | $738.990000 | 100% | Dec 2025 |
|
| Farther Finance Advisors | 200.00 | $422.000000 | 0% | Dec 2025 |
|
| CWM | 147.00 | $0 | -80% | Dec 2025 |
|
| Hartland & Co | 60.00 | $127.002000 | 100% | Dec 2025 |
|
| SRS Capital Advisors | 26.00 | $55.000400 | 0% | Dec 2025 |
|
| Optiver Holding B.V. | 5.00 | $11.000000 | -17% | Dec 2025 |
|
| NBT Bank | 2.00 | $422.000000 | 0% | Dec 2025 |
|
Who sold out of Acumen Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AQR Capital Management | Jun 2025 | 46k | $54k |
| Jain Global | Jun 2025 | 40k | $46k |
| Marex Group | Jun 2025 | 33k | $39k |
| GSA Capital Partners | Sep 2025 | 32k | $55k |
| Jacobs Levy Equity Management | Sep 2025 | 16k | $27k |
| Hrt Financial | Sep 2025 | 14k | $23k |
| Savant Capital Management | Sep 2025 | 11k | $19k |
| Integrated Wealth Concepts | Sep 2025 | 10k | $17k |
| Advisory Services Network | Sep 2025 | 1.1k | $1.9k |
| Raymond James Financial | Jun 2025 | 495.00 | $574.002000 |
| Bell Investment Advisors | Sep 2025 | 362.00 | $619.997400 |